ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -90.6% | 1,500 | -87.0% | 0.00% | -100.0% |
| Q4 2015 | $53,000 | -20.9% | 11,500 | +4.5% | 0.00% | -50.0% |
| Q3 2015 | $67,000 | -48.1% | 11,000 | -26.7% | 0.00% | -33.3% |
| Q2 2015 | $129,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,714,958 | $5,265,000 | 0.34% |
| Broadfin Capital, LLC | 766,329 | $2,353,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $5,194,000 | 0.27% |
| Perceptive Advisors | 431,456 | $1,325,000 | 0.16% |
| Rhenman & Partners Asset Management AB | 119,297 | $366,000 | 0.14% |
| Orbimed Advisors | 932,750 | $2,864,000 | 0.04% |
| Weiss Multi-Strategy Advisers LLC | 210,000 | $645,000 | 0.01% |
| Visium Asset Management, LP | 200,000 | $614,000 | 0.01% |
| MOORE CAPITAL MANAGEMENT, LP | 224,800 | $690,000 | 0.01% |
| Alyeska Investment Group, L.P. | 72,800 | $223,000 | 0.01% |